(Q56507904)

English

Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?

scholarly article by Nanda Gruben et al published November 2014 in BBA: Molecular Basis of Disease

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? (English)

0 references

1 reference

0 references

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

Ronit Shiri-Sverdlov

2

0 references

author name string

Nanda Gruben

series ordinal

1

0 references

Debby P.Y. Koonen

series ordinal

3

0 references

Marten H. Hofker

series ordinal

4

0 references

publication date

November 2014

0 references

published in

BBA: Molecular Basis of Disease

0 references

volume

1842

0 references

issue

11

0 references

page(s)

2329-2343

0 references

cites work

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1002/HEP.22363

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Deletion of tumor necrosis factor-alpha receptor type 1 exacerbates insulin resistance and hepatic steatosis in aromatase knockout mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Ceramides and glucosylceramides are independent antagonists of insulin signaling

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Selective insulin and leptin resistance in metabolic disorders

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The origins and drivers of insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Selective versus total insulin resistance: a pathogenic paradox

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Role of ceramides in nonalcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1371/JOURNAL.PONE.0030668

Regulation of TNF-induced NF-κB activation by different cytoplasmic ubiquitination events

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatocytes: critical for glucose homeostasis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The burden of liver disease in Europe: a review of available epidemiological data

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

NOX4 pathway as a source of selective insulin resistance and responsiveness

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A ceramide-centric view of insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Lipid-induced insulin resistance: unravelling the mechanism

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Animal models of nonalcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Prevention of steatosis by hepatic JNK1

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The metabolically benign and malignant fatty liver

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Human fatty liver disease: old questions and new insights

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Modulation of the JNK pathway in liver affects insulin resistance status

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Increased macrophage migration into adipose tissue in obese mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Hepatic glycosphingolipid deficiency and liver function in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

A lipidomic analysis of nonalcoholic fatty liver disease.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1002/HEP.26046

The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Obesity and diabetes in TNF-alpha receptor- deficient mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1β-induced chronic inflammation

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Animal models of non-alcoholic steatohepatitis: of mice and man.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Kupffer cell activation is a causal factor for hepatic insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice.

2 references

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

28 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.ATHEROSCLEROSIS.2013.11.074

Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mechanisms for insulin resistance: common threads and missing links

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

NF-kappaB: a key role in inflammatory diseases

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver

1 reference

28 October 2023

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBADIS.2014.08.004

Identifiers

DOI

10.1016/J.BBADIS.2014.08.004

0 references

PubMed ID

25128743

0 references

ResearchGate publication ID

264830536

0 references

(Q56507904)

Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)